Tronox's Q1 results were weak, with negative operating income and free cash flow due to high capex and restructuring expenses. 2025 is expected to remain challenging, but management guided for significant EBITDA and cost improvements starting in 2026. Cost savings, plant idling, and South African investments could boost EBITDA by $225M, supporting debt reduction and future profitability.
Tronox (NYSE:TROX) stock appears to be unattractive – rendering it a poor choice to purchase at its present price of roughly $5.70. We think that there are multiple significant issues with TROX stock, making it unappealing even though its current valuation is quite low.
Tronox Holdings plc (NYSE:TROX ) Q1 2025 Results Conference Call May 1, 2025 9:00 AM ET Company Participants Jennifer Guenther - Chief Sustainability Officer, Head of Investor Relations and External Affairs John Romano - Chief Executive Officer John Srivisal - Senior Vice President, Chief Financial Officer Conference Call Participants Peter Osterland - Truist James Cannon - UBS Securities Aziza Gazieva - Fermium Research Caleb Bonnellien - BMO Capital Markets Justin Pellegrino - Morgan Stanley Michael Leithead - Barclays Roger Spitz - Bank of America Merrill Lynch Hassan Ahmed - Alembic Global Advisors Aaron Rosenthal - JPMorgan John Roberts - Mizuho Operator Good morning. Welcome to the Tronox Holdings plc Q1 2025 Earnings Conference Call.
![]() T5X 1 Jun 2015 | Other | €0.72 Per Share |
![]() T5X 27 Feb 2015 | Other | €0.72 Per Share |
![]() T5X 28 Nov 2014 | Other | €0.72 Per Share |
![]() T5X 29 Aug 2014 | Other | €0.72 Per Share |
![]() T5X 30 May 2014 | Other | €0.72 Per Share |
30 Jul 2025 (In 1 week) Date | | - Cons. EPS | - EPS |
23 Jul 2025 (In 2 days) Date | | - Cons. EPS | - EPS |
29 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | 0.06 Cons. EPS | 0.03 EPS |
24 Oct 2024 Date | | 0.16 Cons. EPS | - EPS |
![]() T5X 1 Jun 2015 | Other | €0.72 Per Share |
![]() T5X 27 Feb 2015 | Other | €0.72 Per Share |
![]() T5X 28 Nov 2014 | Other | €0.72 Per Share |
![]() T5X 29 Aug 2014 | Other | €0.72 Per Share |
![]() T5X 30 May 2014 | Other | €0.72 Per Share |
30 Jul 2025 (In 1 week) Date | | - Cons. EPS | - EPS |
23 Jul 2025 (In 2 days) Date | | - Cons. EPS | - EPS |
29 Apr 2025 Date | | - Cons. EPS | - EPS |
13 Feb 2025 Date | | 0.06 Cons. EPS | 0.03 EPS |
24 Oct 2024 Date | | 0.16 Cons. EPS | - EPS |
Chemicals Industry | Basic Materials Sector | John D. Romano CEO | XFRA Exchange | GB00BJT16S69 ISIN |
US Country | 6,500 Employees | 19 May 2025 Last Dividend | 26 Jul 2012 Last Split | 22 Nov 2005 IPO Date |